Roger S. Newton

Roger S. Newton discloses dealings in Esperion Therapeutics, Inc. to SEC (Form 4). The record holds 20 filings, for trades running from 1 July 2013 to 12 March 2019.

The open-market side counts 1 purchase for €454k alongside 15 sales for €4.8M. Sales outweigh purchases by €4.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 1 option exercise. Since January 2019: no purchases and 1 sale on the market.

The record was last updated on 14 March 2019 with an open-market sale (€1.1M) in Esperion Therapeutics, Inc. The clock since the last published purchase (1 July 2013) now reads 4,879 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.